Related Experiment Video

Updated: Mar 27, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.2K

Recent Advances in Targeted Therapies for Adult Gliomas

Aleksandra B Lasica1,2, Alice R Tang1,2, Arooba Iqbal1

  • 1Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Current Neurology and Neuroscience Reports
|March 24, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
GlioblastomaGliomaIDH inhibitorIDH mutantIDH wildtypeTargeted therapy

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K

Related Experiment Videos

Last Updated: Mar 27, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.2K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K

Articles linked to this work by shared authors, journal, and citation graph.

Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

Science translational medicine·2026

Comparison of low molecular weight heparins with direct oral anticoagulants for the prevention of venous thromboembolism in major abdominopelvic surgeries: A systematic review and meta-analysis.

Journal of perioperative practice·2026

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Neuro-oncology advances·2026

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Neuro-oncology·2025

Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective.

Current opinion in neurology·2025

Off-label use of Avastin in Pakistan: Lessons from the 2023 Punjab outbreak.

Journal of public health research·2025

Genetic Diagnosis in Epilepsy: Implications for Clinical Management.

Current neurology and neuroscience reports·2026

Low-cost Rehabilitation Solutions: Lessons From LMIC Settings.

Current neurology and neuroscience reports·2026

Traumatic Brain Injury in Austere Environments: a Review of Recent Advances.

Current neurology and neuroscience reports·2026

Sleep in Children with Neurodevelopmental Disorders: From Diagnostic Labels to Phenotype-directed Care.

Current neurology and neuroscience reports·2026

Challenges and Adjunctive Use of CT Perfusion (CTP) in Acute Stroke: Pitfalls, False Negatives, and Diagnostic Clues for Stroke Mimics.

Current neurology and neuroscience reports·2026

Pulsed Radiofrequency for Post-Stroke Complications: From Neuromodulation to Functional Recovery.

Current neurology and neuroscience reports·2026

Are Urooncologists Onboard?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

The State of the Art of Theranostics and Its Future.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[Alzheimer's disease: scientific advances, diagnostic challenges and therapeutic perspectives].

Soins; la revue de reference infirmiere·2026

Photobiomodulation therapy and the regulation of excitation-inhibition balance in neurological and psychiatric disorders: Mechanistic and translational perspectives.

Neuroscience·2026

Threshold Price of Belantamab for Relapsed/Refractory Multiple Myeloma in China: A Cost-Effectiveness Analysis.

PharmacoEconomics - open·2026

MiR-590-3p Targets HMGB1 to Alleviate Endothelial Injury Induced by β2GPI/Anti-β2GPI Immune Complex.

International journal of immunogenetics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us